LIPTRUZET - 66582-320-27 - (ezetimibe and atorvastatin)

Alphabetical Index


Drug Information of LIPTRUZET

Product NDC: 66582-320
Proprietary Name: LIPTRUZET
Non Proprietary Name: ezetimibe and atorvastatin
Active Ingredient(s): 10; 10    mg/1; mg/1 & nbsp;   ezetimibe and atorvastatin
Administration Route(s): ORAL
Dosage Form(s): TABLET, FILM COATED
Coding System: National Drug Codes(NDC)

Labeler Information of LIPTRUZET

Product NDC: 66582-320
Labeler Name: Merck Sharp & Dohme Corp.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA200153
Marketing Category: NDA
Start Marketing Date: 20130503

Package Information of LIPTRUZET

Package NDC: 66582-320-27
Package Description: 4 POUCH in 1 CARTON (66582-320-27) > 1 BLISTER PACK in 1 POUCH (66582-320-11) > 7 TABLET, FILM COATED in 1 BLISTER PACK

NDC Information of LIPTRUZET

NDC Code 66582-320-27
Proprietary Name LIPTRUZET
Package Description 4 POUCH in 1 CARTON (66582-320-27) > 1 BLISTER PACK in 1 POUCH (66582-320-11) > 7 TABLET, FILM COATED in 1 BLISTER PACK
Product NDC 66582-320
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name ezetimibe and atorvastatin
Dosage Form Name TABLET, FILM COATED
Route Name ORAL
Start Marketing Date 20130503
Marketing Category Name NDA
Labeler Name Merck Sharp & Dohme Corp.
Substance Name ATORVASTATIN CALCIUM; EZETIMIBE
Strength Number 10; 10
Strength Unit mg/1; mg/1
Pharmaceutical Classes Decreased Cholesterol Absorption [PE],Dietary Cholesterol Absorption Inhibitor [EPC],HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]

Complete Information of LIPTRUZET


General Information